News >

Novel Strategies Emerging to Tackle Heterogeneity of TNBC

Caroline Seymour
Published: Monday, Jul 08, 2019

Kari B. Wisinski, MD

Kari B. Wisinski, MD

Metastatic triple-negative breast cancer (TNBC) is a disease in which treatment was once heavily rooted in chemotherapy. Now, with the emergence of novel agents, clinicians are learning how to treat the heterogeneity of the disease appropriately, explained Kari B. Wisinski, MD, in a presentation during the 2019 OncLive® State of the Science Summit on Breast Cancer.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: PARP Inhibition in Breast Cancer: Practical Methods to Interpret and Apply the Evidence for Your PatientsAug 30, 20191.5
Provider and Caregiver Connection™: Addressing Patient Concerns in the Management of Premenopausal Breast CancerAug 31, 20192.0
Publication Bottom Border
Border Publication